Literature DB >> 8674872

Biochemical and molecular mechanisms in the development of diabetic vascular complications.

G L King1, M Kunisaki, Y Nishio, T Inoguchi, T Shiba, P Xia.   

Abstract

Hyperglycemia is the major causal factor in the development of diabetic vascular complications. The mechanism by which hyperglycemia causes the complications is not clear; however, it is very likely that hyperglycemia is mediating its adverse effects through multiple mechanisms. We have summarized some of these mechanisms in this review, with particular attention to the effect of hyperglycemia on the activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway. We have reviewed existing information regarding various vascular tissues that show increased DAG and PKC levels. In addition, the mechanism by which hyperglycemia increases DAG as well as the cellular physiological consequences on the activation of PKC have been reviewed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8674872     DOI: 10.2337/diab.45.3.s105

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  21 in total

Review 1.  Regulation of the Na+/K+-ATPase by insulin: why and how?

Authors:  G Sweeney; A Klip
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

2.  Inhibitory mechanism of vascular endothelial growth factor (VEGF) by bucillamine.

Authors:  Shinji Koyama; Hitoshi Takagi; Atsushi Otani; Hideyasu Oh; Kazuo Nishimura; Yoshihito Honda
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

3.  Elevated D-glucose induces insulin insensitivity in human umbilical endothelial cells isolated from gestational diabetic pregnancies.

Authors:  L Sobrevia; D L Yudilevich; G E Mann
Journal:  J Physiol       Date:  1998-01-01       Impact factor: 5.182

4.  Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells.

Authors:  S Koyama; H Takagi; A Otani; K Suzuma; K Nishimura; Y Honda
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

Review 5.  MicroRNAs and diabetic complications.

Authors:  Rama Natarajan; Sumanth Putta; Mitsuo Kato
Journal:  J Cardiovasc Transl Res       Date:  2012-05-03       Impact factor: 4.132

6.  Regulation of adenosine transport by D-glucose in human fetal endothelial cells: involvement of nitric oxide, protein kinase C and mitogen-activated protein kinase.

Authors:  V P Montecinos; C Aguayo; C Flores; A W Wyatt; J D Pearson; G E Mann; L Sobrevia
Journal:  J Physiol       Date:  2000-12-15       Impact factor: 5.182

Review 7.  The link between Glut-1 and hypertension in diabetic nephropathy.

Authors:  Luigi Gnudi; Leopoldo Raij
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

Review 8.  Hyperglycemia-induced oxidative stress in diabetic complications.

Authors:  George L King; Mary R Loeken
Journal:  Histochem Cell Biol       Date:  2004-07-15       Impact factor: 4.304

9.  Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells.

Authors:  Megan E Cavet; Elaine M Smolock; Oktay H Ozturk; Cameron World; Jinjiang Pang; Atsushi Konishi; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-21       Impact factor: 8.311

10.  Expression of thromboxane synthase and the thromboxane-prostanoid receptor in the mouse and rat retina.

Authors:  William S Wright; Robert M McElhatten; Norman R Harris
Journal:  Exp Eye Res       Date:  2009-06-11       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.